The new IPO: Lower costs, less chaos
February 10, 2014 at 17:38 PM EST
When it came time for Kindred Biosciences Inc.'s $53 million IPO at the end of last year, CEO Richard Chin had a choice to make: The one-year-old Burlingame company could assemble, print and file its bulky and anxiety-filled S-1 document the traditional way, or it could break new ground using a fast-growing software firm's time-saving product...
